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OBJECTIVES: Acute ST-segment elevation myocardial infarction patients presenting persistent no-flow after
wire insertion have a lower survival rate despite successful mechanical intervention. The neutrophil-to-
lymphocyte ratio has been associated with increased mortality and worse clinical outcomes in ST-segment
elevation myocardial infarction. We hypothesized that an elevated neutrophil-to-lymphocyte ratio would also
be associated with a persistent Thrombolysis In Myocardial Infarction flow grade of 0 after wire insertion in
patients undergoing primary percutaneous coronary intervention.
METHODS: A total of 644 patients with ST-segment elevation myocardial infarction who underwent primary
percutaneous coronary intervention within 12 hours of symptom onset were included in our study. Blood
samples were drawn immediately upon hospital admission. The patients were divided into 3 groups according
to their Thrombolysis In Myocardial Infarction flow grade: Thrombolysis In Myocardial Infarction flow grade 0
after wire insertion, Thrombolysis In Myocardial Infarction flow grade 1-3 after wire insertion and Thrombolysis
In Myocardial Infarction flow grade 1-3 at baseline.
RESULTS: The neutrophil-to-lymphocyte ratio was significantly higher in the group with Thrombolysis In
Myocardial Infarction flow grade 0 after wire insertion compared with the group with Thrombolysis In
Myocardial Infarction flow grade 1-3 after wire insertion and the group with Thrombolysis In Myocardial
Infarction flow grade 1-3 at baseline. The group with Thrombolysis In Myocardial Infarction flow grade 0 after
wire insertion also had a significantly higher in-hospital mortality rate. Persistent coronary no-flow after wire
insertion was independently associated with the neutrophil-to-lymphocyte ratio.
CONCLUSIONS: An increased neutrophil-to-lymphocyte ratio on admission is significantly associated with
persistent coronary no-flow after wire insertion in patients with ST-segment elevation myocardial infarction
undergoing primary percutaneous coronary intervention.
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& INTRODUCTION
Primary percutaneous coronary intervention (PPCI) is an
established therapeutic strategy for ST-elevation myocardial
infarction (STEMI) (1), and the Thrombolysis In Myocardial
Infarction (TIMI) flow grade is a scoring method for
assessing coronary blood flow both before and after
reperfusion (2). The baseline TIMI flow before intervention
in an infarct-related artery (IRA) has been previously shown
to influence mortality in patients with STEMI undergoing
PPCI (3). However, the patency of the IRA before PPCI in
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patients with STEMI is a major determinant of TIMI flow 3
after PPCI, which is associated with an improved clinical
outcome (4). In contrast, STEMI patients displaying persis-
tent no-flow after wire insertion (AWI) have a lower
survival rate despite apparently successful PPCI (5).
Atherosclerosis is an inflammatory disease (6).
Inflammation promotes coronary atherosclerotic plaque
rupture and atherothrombosis (7), which are the main
mechanisms in the pathophysiology of acute STEMI.
Leukocytosis is a marker of inflammation and is associated
with the inflammatory response at plaque sites in patients
with STEMI (6-8). As part of this inflammatory reaction,
cytokines such as interleukin (IL)-6, IL-8 and CD40 ligand
trigger the upregulation of monocyte tissue factor expres-
sion, which may facilitate the extrinsic pathway of the
coagulation cascade (9). The neutrophil-to-lymphocyte ratio
(NLR) has also emerged as an important inflammatory
marker for cardiovascular risk stratification (10). Previously,
several studies established that an elevated NLR was
associated with early IRA patency before PPCI, the
development of no-reflow after PPCI, increased mortality
and worse cardiovascular outcomes in acute STEMI (11-13).
However, the relationship between the admission NLR and
coronary flow AWI in STEMI patients has not been
assessed. Thus, we investigated whether an elevated NLR,
as measured on admission, is associated with a persistent
TIMI flow grade of 0 AWI in patients with acute STEMI
undergoing mechanical reperfusion.
& METHODS
Between July 2012 and April 2014, consecutive patients
who were hospitalized at our institution because of acute
STEMI and who underwent PPCI within 12 hours after
diagnosis were enrolled in our study. Initially, 669 patients
were eligible for this study. In total, 25 patients were
excluded from the study for the following reasons: 5
patients had unavailable laboratory data, 2 patients had
multivessel intervention, 10 patients had been treated with
an urgent coronary artery bypass graft due to failed PPCI or
had coronary anatomy that was not amenable to PPCI, 3
patients had severe renal failure and 5 patients had acute or
chronic infection/inflammation. Therefore, a total of 644
patients were ultimately included in our study. The mean
age was 60¡13 years and 480 (74.5%) of the patients were
men.
The definition of STEMI was based on criteria for the
classic symptoms of coronary ischemia and the detection of
a 1-mm ST-segment elevation in the inferior leads, a 2-mm
ST-segment elevation in the anterior chest leads occurring in
two contiguous leads (or reciprocal ST depression $1 mm
in V1 or V2), or the presence of a new (or presumably new)
left bundle branch block. Patients with active infection,
previously proven chronic inflammatory disease, known
malignancy, advanced-stage liver or renal disorders, or
fibrinolytic administration in the previous 30 days were
excluded from this study. To avoid the confounding effect
of multiple lesions, only patients who underwent PPCI in a
single IRA, without the treatment of additional lesions were
considered. The patients were divided into 3 groups
according to their TIMI flow grade: AWI TIMI flow grade
0 group, AWI TIMI flow grade 1-3 group and baseline TIMI
flow grade 1-3 group. The study protocol was approved by
the institutional review board at our hospital and all
patients gave written informed consent before study entry.
All procedural parameters were evaluated by two
independent experienced interventional cardiologists using
quantitative cardiovascular angiographic software (Axiom
Sensis XP; Siemens, Munich, Germany). The Syntax scores
of all patients (except for coronary artery bypass grafting
(CABG) patients) were calculated by two independent
experienced interventional cardiologists who were blinded
to the identities of the patients and to the patients’ clinical
information from baseline diagnostic angiography (14).
Each lesion with $50% diameter stenosis in vessels
$1.5 mm in diameter was scored using an online calculator,
version 2.1, at www.syntaxscore.com. Additionally, the
TIMI flow grade was visually assessed in all patients. The
TIMI flow grade was measured as follows: 0 = complete
vessel occlusion with no angiographic visualization of the
vessel beyond the site of stenosis (no perfusion); 1 =
penetration without perfusion; 2 = partial reperfusion and
3 = complete filling of the distal vessel by the third cardiac
cycle (complete reperfusion) (15). As part of the protocol in
this study, operators were requested to film coronary flow
before (pre-PPCI flow) and immediately after (TIMI AWI)
wire insertion, which was defined as satisfactory position-
ing of the wire completely down the length of the IRA, as
well as upon removal of the wire after the intervention
(post-PPCI flow). Procedural success for coronary stent
placement was defined as achieving a minimum stenosis
diameter reduction to less than 20% in the IRA, along with
TIMI grade 3 coronary flow. The median door-to-balloon
interval was 40 (32-55) minutes in our study.
Blood samples were drawn immediately upon hospital
admission, before PPCI. Routine complete blood cell counts
(XE-2100; Sysmex Inc., Japan) and blood chemistry mea-
surements (glucose, creatinine) were then performed at our
hospital. Cardiac enzyme (creatinine kinase-myocardial
band (CK-MB), troponin T) levels, lipid profiles and high-
sensitivity C-reactive protein (hs-CRP) levels were also
measured in all patients. The NLR was calculated as the
ratio of the neutrophil count to the lymphocyte count.
Moreover, to evaluate kidney function, the estimated
glomerular filtration rate (eGFR) was obtained by applying
the Modification of Diet in Renal Disease Study formula. To
assess cardiac function, transthoracic echocardiography was
routinely performed on each patient within 48 hours
following PPCI (Vivid 3; GE Medical Systems, Horten,
Norway). The left ventricular ejection fraction (LVEF)
was also measured using the Simpson method according
to the recommendations of the American Society of
Echocardiography (16).
All patients received a single loading dose of 600 mg
clopidogrel and 300 mg aspirin immediately after arrival at
the hospital. In addition, all patients received an intrave-
nous bolus injection of 5000 U heparin before angiography.
Baseline coronary angiography was performed by the
femoral approach using the standard Judkins technique
(Siemens Axiom Artis zee 2011; Siemens Healthcare,
Erlangen, Germany). According to established guidelines,
only culprit lesions were treated using standard PCI
techniques and a 6-Fr guiding catheter (Launcher;
Medtronic, Minneapolis, Minnesota, USA). According to
patient characteristics and angiographic features, the selec-
tion of the type of stent (bare metal or drug eluting) and the
decision to use a glycoprotein IIb/IIIa antagonist (tirofiban)
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or an intra-aortic balloon pump were left to the discretion of
the operator. Additionally, the use of pre- or post-dilation and
thrombus aspiration was left to the discretion of the treating
physician. The IRA was the only target of the procedure,
except in the case of cardiogenic shock. A 75 mg clopidogrel
dose was administered for at least 12 months after the PPCI
and 100 mg aspirin was prescribed indefinitely.
Statistical analysis was performed using the SPSS 18.0
statistical package for Windows (SPSS Inc., Chicago, IL,
USA). Quantitative variables are expressed as the mean¡
standard deviation or as the median and interquartile range.
Continuous variables were analyzed for normal distribution
using the Kolmogorov-Smirnov test and analyzed for
homogeneity using the Levene test. Comparisons of para-
metric values among groups were performed using one-way
ANOVA. Comparisons of non-parametric values among
groups were performed using the Kruskal-Wallis test.
Tukey’s HSD (for parametric variables) and the Bonferroni-
adjusted Mann-Whitney U-test (for non-parametric vari-
ables) were used as post hoc tests for multiple comparisons
between groups. A two-tailed p-value,0.05 was considered
statistically significant. A receiver operating characteristic
(ROC) analysis was also performed to identify the best cutoff
value for the NLR and the sensitivity and specificity at that
point were obtained for predicting persistent coronary no-flow
AWI. Univariate logistic regression was additionally used to
identify independent predictors of TIMI flow grade 0 AWI.
After performing the univariate analysis, significant variables
(age, smoking, systolic blood pressure (SBP), LVEF, hemoglo-
bin, eGFR, total cholesterol, NLR, peak CK-MB, hs-CRP, white
blood cell (WBC) count, Syntax score and Killip class $2 on
admission) were used in a multivariate logistic regression
analysis. We also performed a multivariate logistic regression
analysis to evaluate data the NLR versus in-hospital mortality,
coronary no-flow, peak CK-MB and the Syntax score and in-
hospital mortality versus the NLR cutoff value, the Syntax
score, peak CK-MB and no-flow in our study population.
& RESULTS
The baseline clinical characteristics of the patients in the 3
groups, divided according to the coronary TIMI flow grade
are shown in Table 1. The group with persistent coronary
no-flow AWI was older, contained fewer smokers, had a
lower initial SBP and lower LVEF values, and more
commonly had Killip class $2 on admission. Compared
with patients with TIMI flow grade 1-3 at baseline and TIMI
flow grade 1-3 AWI, patients with persistent coronary no-
flow (TIMI 0) AWI had higher cardiac enzyme (CK-MB,
troponin T) and hs-CRP levels, higher WBC and neutrophil
counts and a lower lymphocyte count. These patients also
had significantly lower hemoglobin, total cholesterol and
triglyceride levels (Table 2). The NLR was significantly
higher in the AWI TIMI flow 0 group compared with the
AWI TIMI flow 1-3 and baseline TIMI flow 1-3 groups
(7.74¡4.96, 4.22¡2.53 and 3.39¡2.03, respectively,
p,0.001). Figure 1 and Table 2 show the frequency
distribution of the NLR according to the groups.
A total of 26 (4.0%) cases of mortality were documented
during hospitalization. The AWI TIMI flow 0 group had a
higher rate of in-hospital mortality compared with the AWI
TIMI flow 1-3 and baseline TIMI flow 1-3 groups (13 (7.0), 6
(4.3) and 7 (2.2), respectively, p= 0.028) (Table 2). We found
Table 1 - Baseline characteristics and prior medications of the study population.
Baseline TIMI Flow Grade 0 (n = 324)
After Wire Insertion
Variable TIMI 0 (n= 185) TIMI 1-3 (n= 139) Baseline TIMI Flow Grade 1-3 (n = 320) p value
Age, years 63¡13 59¡13 59¡12 0.001
Male gender, n (%) 129 (69.7) 105 (75.5) 246 (76.9) 0.197
Body mass index, kg/m2 27.2¡4.4 27.3¡4.0 27.9¡4.1 0.237
Hypertension, n (%) 83 (44.9) 53 (38.1) 123 (38.4) 0.311
Diabetes mellitus, n (%) 65 (35.1) 34 (24.5) 101 (31.6) 0.116
Smoking, n (%) 80 (43.2) 81 (58.3) 159 (49.7) 0.028
Hyperlipidemia, n (%) 56 (30.2) 50 (36.0) 117 (36.6) 0.293
Family history, n (%) 43 (23.2) 44 (31.7) 86 (26.9) 0.240
Prior stroke, n (%) 6 (3.2) 0 (0) 6 (1.9) 0.102
Prior CABG, n (%) 4 (2.2) 4 (2.9) 11 (3.4) 0.716
Prior myocardial infarction, n (%) 11 (5.9) 3 (2.2) 13 (4.1) 0.239
Systolic blood pressure, mmHg 122¡25 127¡26 130¡23 0.006
Heart rate, beats/min 81¡17 78¡15 79¡15 0.185
Anterior infarct, n (%) 86 (46.5) 48 (34.5) 151 (47.2) 0.019
Killip class $2 on admission 29 (15.7) 7 (5.0) 14 (4.4) ,0.001
LVEF, % 42¡10 45¡9 47¡10 ,0.001
Symptoms prior to PPCI, min 222¡115 210¡136 175¡121 0.225
,6 hours, n (%) 134 (72.4) 113 (81.3) 241 (75.3) 0.176
$6 hours, n (%) 51 (27.6) 26 (18.7) 79 (24.7)
Preinfarct angina, n (%) 46 (25.0) 41 (29.7) 111 (34.7) 0.557
Medications before hospitalization (%)
Aspirin 18.5 20.8 23.8 0.190
Clopidogrel 9.3 12.5 14.2 0.458
ACEI or ARB 32.0 28.3 33.3 0.708
Beta-blocker 12.0 8.9 7.8 0.707
Statin 4.0 4.4 4.4 0.991
TIMI: Thrombolysis In Myocardial Infarction; CABG: coronary artery bypass grafting; LVEF: left ventricular ejection fraction; PPCI: primary percutaneous
coronary intervention; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker.
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that in-hospital mortality was independently associated
with an increased NLR and increased no-flow (OR 1.52,
p= 0.004 and OR 3.1, p,0.001, respectively). In addition, the
percentage of complete ($70%) ST-segment resolution on
electrocardiography after PPCI was significantly lower in
the AWI TIMI flow 0 group compared with the AWI TIMI
flow 1-3 and baseline TIMI flow 1-3 groups (p,0.001).
The baseline angiographic and procedural characteristics
of the study population are presented in Table 3. The
number of diseased vessels and the prevalence of multi-
vessel disease were similar among the groups (p= 0.252 and
p= 0.277, respectively). The IFAs of patients with TIMI flow
grade 1-3 AWI were less frequently located in the left
anterior descending coronary artery, whereas in patients
Table 2 - Baseline biochemical and hematologic measurements for the study population.
Baseline TIMI Flow Grade 0 (n = 324)
After Wire Insertion
Variable TIMI 0 (n= 185) TIMI 1-3 (n = 139) Baseline TIMI Flow Grade 1-3 (n = 320) p value
Serum glucose (mg/dL) 152¡71 140¡74 143¡69 0.260
Hemoglobin A1c (%) 6.71¡1.75 6.62¡1.64 6.85¡2.03 0.511
Creatinine (mg/dL) 1.15¡0.34 1.09¡0.50 1.09¡0.26 0.157
eGFR (mL/min/1.73 m2) 67¡20 76¡20 73¡19 0.001
Peak CK-MB (ng/mL) 137 (60-295) 116 (63-181) 59 (32-127) ,0.001
Peak troponin T (ng/mL) 3245 (1279-6648) 1850 (838-4633) 1030 (431-2214) ,0.001
hs-CRP (mg/dL) 9.03¡3.21 7.98¡3.63 6.95¡3.84 ,0.001
Low-density lipoprotein (mg/dL) 112¡40 124¡38 126¡41 0.001
High-density lipoprotein (mg/dL) 40.4¡10.2 40.5¡9.0 40.5¡9.4 0.995
Triglyceride (mg/dL) 122 (82-171) 137 (106-201) 149 (104-198) 0.010
Total cholesterol (mg/dL) 180¡47 194¡42 192¡49 ,0.001
Hemoglobin (g/L) 13.73¡2.04 14.26¡1.78 14.29¡1.76 0.003
Platelet count (x103/mL) 243¡76 239¡62 244¡70 0.791
Mean platelet volume (fL) 8.84¡1.18 8.63¡0.90 8.71¡1.03 0.121
White blood cell count (x103/mL) 12.44¡3.70 11.86¡3.78 11.33¡3.39 0.001
Neutrophil count 8.42¡3.26 8.81¡3.31 7.26¡2.81 ,0.001
Lymphocyte count 1.62¡0.75 2.41¡1.08 2.69¡1.38 ,0.001
Neutrophil-to-lymphocyte ratio 7.74¡4.96 4.22¡2.53 3.39¡2.03 ,0.001
Complete STR on electrocardiography 83 (44.8) 102 (73.7) 247 (77.2) ,0.001
In-hospital mortality 13 (7.0) 6 (4.3) 7 (2.2) 0.028
TIMI: Thrombolysis In Myocardial Infarction; eGFR: estimated glomerular filtration rate; CK-MB: creatine kinase-myocardial band; hs-CRP: high-sensitivity
C-reactive protein; STR: ST-segment resolution.
Figure 1 - Comparison of neutrophil-to-lymphocyte ratio (NLR) values among the groups.
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with baseline TIMI flow grade 0, the culprit lesions were
more commonly located in the right coronary artery
(p= 0.024). TIMI flow grade 0 was present before PPCI in
51.9% (n = 334) of infarct vessels and suboptimal flow (TIMI
flow grade 1-2) was found in 25.0% (n = 161), whereas the
remainder of infarct arteries presented with TIMI flow
grade 3. As shown in Table 3, a final TIMI flow grade of 3
was achieved in 56.2% (n = 104) of patients with TIMI flow
grade 0 AWI and in 87.8% (n = 122) of patients with
TIMI flow grade 1-3 AWI; the remainder of patients
had TIMI flow grade 1-3 at baseline. However, patients
with TIMI flow grade 0 with persistent coronary no-flow
after passage of the wire had a significantly lower
prevalence of stent implantation, a lower rate of direct
stenting, a higher total stent length and higher rate of
balloon predilatation compared with those with TIMI flow
grade 1-3 AWI and TIMI flow grade 1-3 at baseline (p,0.001
in post hoc analysis) (Table 3). Additionally, patients
presenting with TIMI flow grade 0 had a significantly
higher prevalence of tirofiban use compared with those with
TIMI flow grade 1-3 at baseline (p= 0.006 in post hoc
analysis). The multivariate logistic regression analysis
showed that persistent coronary no-flow (TIMI 0) AWI
was independently associated with the NLR (OR 1.421, 95%
CI 1.274-1.585, p,0.001), peak CK-MB (OR 1.004, 95% CI
1001-1.007, p= 0.005) and the Syntax score (OR 1.058, 95% CI
1.021-1.096, p= 0.002) (Table 4). In the ROC curve analysis,
an NLR.4.34 independently predicted TIMI flow 0 AWI,
with 72% sensitivity and 70% specificity (AUC 0.801, 95% CI
0.765-0.837) (Figure 2). We also found that an NLR.4.34
was independently associated with the Syntax score (OR
1.035, p= 0.004), no-flow (OR 3.044, p,0.001) and peak CK-
MB (OR 1.003, p= 0.001).
& DISCUSSION
To the best of our knowledge, this is the first study to
identify an association between the NLR and coronary flow
AWI in patients with STEMI undergoing PPCI. The main
finding in this study was that an increased NLR value on
admission was a strong and independent predictor of
persistent coronary no-flow AWI in patients with STEMI
undergoing mechanical reperfusion. In addition, the
patients with TIMI flow grade 0 AWI had a higher rate of
in-hospital mortality.
The early restoration of coronary flow in an IRA recovers
ventricular performance and decreases mortality in patients
with STEMI (3). Brodie et al. (3) were the first to report a
different survival pattern in patients presenting with TIMI
flow grade 2 or 3 before intervention compared with
patients with baseline TIMI flow grade 0 or 1. Moreover,
STEMI patients presenting persistent no-flow AWI have a
lower survival rate despite apparently successful mechan-
ical intervention (5). Atherosclerosis is an inflammatory
process (6) and inflammatory markers have been identified
as useful predictors of clinical outcomes. In particular, the
NLR has emerged as an important inflammatory marker for
cardiovascular risk stratification (10). Akpek et al. (13)
showed that the NLR was independently associated with
the development of no-reflow and in-hospital major adverse
cardiac events in patients with STEMI undergoing PPCI. In
a recently published study, we also demonstrated that the
NLR is associated with early patency of the IRA before PPCI
in patients with STEMI (11).
There are several possible explanations for why an
increased NLR value on admission was an independent
predictor of persistent coronary no-flow AWI in patients
with STEMI undergoing PPCI in our study.
First, the NLR is a sign of balance between neutrophil and
lymphocyte counts in the body and is an indicator of
systemic inflammation (17). Increased inflammation in
patients with coronary artery disease may be linked to
more extensive atheroma (18,19) and the association
between thrombotic and inflammatory pathways in acute
coronary syndromes has been previously shown.
Atherosclerotic plaque rupture is an inflammatory process
mediated by the complex interplay between innate neutro-
phil-mediated reactive immune responses and subsequent
Table 3 - Baseline angiographic and procedural characteristics of the study population.
Baseline TIMI Flow Grade 0 (n= 324)
After Wire Insertion
Variable TIMI 0 (n = 185) TIMI 1-3 (n= 139) Baseline TIMI Flow Grade 1-3 (n = 320) p value
Multivessel disease, n (%) 105 (56.8) 73 (52.5) 158 (49.4) 0.277
Single-vessel disease, n (%) 81 (43.8) 66 (47.5) 165 (51.6) 0.550
Double-vessel disease, n (%) 62 (33.5) 43 (30.9) 95 (29.7)
Triple-vessel disease, n (%) 42 (22.7) 30 (21.6) 60 (18.8)
Number of diseased vessels, n (%) 1.79¡0.79 1.74¡0.79 1.72¡0.78 0.252
Infarct-related artery, n (%)
Left anterior descending 86 (46.5) 49 (35.3) 160 (50.0) 0.024
Left circumflex 24 (13.0) 20 (14.4) 57 (17.8)
Right 75 (40.5) 69 (49.6) 101 (31.6)
Left main 0 (0) 1 (0.7) 2 (0.6)
Chronic total occlusion, n (%) 32 (16.3) 16 (11.5) 45 (14.1) 0.329
Thrombus aspiration, n (%) 30 (16.2) 21 (15.0) 44 (13.8) 0.560
Stent deployed, n (%) 155 (83.8) 136 (97.8) 302 (94.4) ,0.001
Number of stents used 1.32¡0.60 1.26¡0.54 1.23¡0.45 0.232
Total stent length, mm 27.42¡11.84 23.86¡11.87 20.91¡8.52 ,0.001
Direct stenting, n (%) 5 (2.7) 78 (56.1) 229 (71.6) ,0.001
Stent with balloon predilatation, n (%) 147 (79.5) 56 (40.3) 68 (21.3) ,0.001
Tirofiban therapy, n (%) 91 (49.2) 68 (48.9) 117 (36.6) 0.006
Procedural success, n (%) 104 (56.2) 122 (87.8) 275 (89.6) ,0.001
Syntax score 20.4¡8.3 18.4¡8.0 12.7¡7.8 ,0.001
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lymphocyte-mediated adaptive immune responses.
Neutrophils are the first leukocytes found in the damaged
myocardial area. Procoagulants are secreted locally by the
leukocytes, increasing the oxidative and proteolytic damage.
Lymphocytes also have an essential role in modulating the
inflammatory response at different stages of the athero-
sclerotic process (20). In an acute setting, lymphopenia is a
common finding during a stress response, secondary to
increased levels of corticosteroids (21). Under pathologic
conditions, defective clearance of apoptotic cells due to poor
phagocytosis of apoptotic cells results in secondary, necrosis-
inducing secretion of proinflammatory cytokines (tumor
necrosis factor-a and IL-6). In addition, lymphopenia has
been reported in critical inflammatory states due to increased
lymphocyte apoptosis (22).
Second, neutrophil infiltration can contribute to no-reflow
by increasing blood viscosity and hypercoagulability. As
part of this inflammatory reaction, cytokines such as IL-6,
IL-8 and CD40 ligand trigger the upregulation of monocyte
tissue factor expression, which may facilitate the extrinsic
pathway of the coagulation cascade (23). Additionally, the
distal embolization of leukocytes and platelet-leukocyte
aggregates might contribute to reduced downstream micro-
vascular perfusion as well as to thrombosis and widespread
myocardial inflammation (8).
Third, it has been shown that a higher WBC count is
correlated with the infarct size (24). After AMI, the release of
chemoattractants draws neutrophils into the infarct zone
during the first 6 hours of myocardial reperfusion; during
the next 24 hours, the cells migrate into the myocardial
Table 4 - Univariate and multivariate predictors of Thrombolysis In Myocardial Infarction 0 flow grade in ST-segment
elevation myocardial infarction after wire insertion.
Univariate Analysis Multivariate Analysis
Variable Odds Ratio, 95% CI p-value Odds Ratio, 95% CI p-value
Age 1.026 (1.012-1.039) ,0.001 1.003 (0.973-1.033) 0.864
Smoking 0.695 (0.493-0.980) 0.038 0.657 (0.331-1.307 0.231
Systolic blood pressure 0.989 (0.982-0.996) 0.002 1.004 (0.992-1.015) 0.544
Left ventricular ejection fraction 0.950 (0.932-0.968) ,0.001 0.991 (0.960-1.024) 0.591
White blood cell count 1.079 (1.030-1.130) 0.001 0.929 (0.846-1.019) 0.119
Hemoglobin 0.856 (0.782-0.937) 0.001 0.906 (0.763-1.075) 0.906
Estimated glomerular filtration rate 0.984 (0.975-0.992) ,0.001 0.994 (0.978-1.010) 0.463
Syntax score 1.083 (1.060-1.106) ,0.001 1.058 (1.021-1.096) 0.002
Total cholesterol 0.992 (0.988-0.996) ,0.001 0.994 (0.988-1.000) 0.059
Neutrophil-to-lymphocyte ratio 1.466 (1.363-1.577) ,0.001 1.421 (1.274-1.585) ,0.001
Creatine kinase-myocardial band 1.006 (1.004-1.008) ,0.001 1.004 (1001-1.007) 0.005
High-sensitivity C-reactive protein 1.152 (1.089-1.219) ,0.001 1.050 (0.973-1.133) 0.212
Killip class $2 on admission 3.875 (2.145-6.993) ,0.001 1.581 (0.462-5.414) 0.465
AWI: after wire insertion; TIMI: Thrombolysis In Myocardial Infarction; STEMI: ST-segment elevation myocardial infarction.
Figure 2 - Receiver operating characteristic (ROC) curve analysis of the use of neutrophil-to-lymphocyte ratio (NLR) values for predicting
persistent coronary no-flow after wire insertion (AWI) (AUC 0.801, 95% CI 0.765-0.837).
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tissue (24). Neutrophil infiltration is regulated through a
complex sequence of molecular steps involving selectins
and integrins, which mediate leukocyte rolling and adhe-
sion to the endothelium (25). These neutrophils cause
proteolytic and oxidative damage to the endothelial cells,
plug the microvasculature, and induce hypercoagulability
and may promote infarct expansion (24,25). As we have
found that peak CK-MB and troponin T levels were elevated
and the LVEF was decreased in patients with TIMI flow
grade 0 AWI, the NLR may act as a combined surrogate
marker for both the reactive and the adaptive components
of the inflammatory response that results in plaque rupture,
ischemic myocardial damage, adverse ventricular remodel-
ing and consequent LV dysfunction (26).
Our study has certain limitations. First, inflammatory
markers other than hs-CRP were not analyzed and
compared with the NLR. Second, the myocardial blush
score, which is a well-known prognostic indicator in STEMI
patients (27), was not assessed in our study. Finally, the
NLR was measured only at the time of admission to
evaluate its prognostic impact. In conclusion, the NLR is a
strong independent predictor of persistent coronary no-flow
AWI in patients with STEMI undergoing mechanical
revascularization. Patients with STEMI in whom persistent
no-flow AWI is detected during PPCI are at greater risk for
in-hospital mortality. As an early and readily available
prognostic marker, the NLR may thus be useful in the early
risk stratification of STEMI patients treated via PPCI.
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